Journal
JOURNAL OF CHEMOTHERAPY
Volume 23, Issue 2, Pages 77-79Publisher
TAYLOR & FRANCIS LTD
DOI: 10.1179/joc.2011.23.2.77
Keywords
Ureaplasma; antimicrobial susceptibility; roxithromycin; clarithromycin; azithromycin; levofloxacin; moxifloxacin
Ask authors/readers for more resources
The in vitro activity of tetracycline, doxycycline, erythromycin, roxithromycin, clarithromycin, azithromycin, levofloxacin and moxifloxacin was tested against 63 clinical isolates of Ureaplasma urealyticum. The minimal inhibitory concentrations (MICs) and the minimal bactericidal concentrations (MBCs) were determined by the broth microdilution method in A7 medium. The MIC50 and MIC90 of the tested agents after 24 h of incubation were as follows: tetracycline, 0.5 and 2.0 mu g/ml; doxycycline, 0.125 and 0.25 mu g/ml; erythromycin, 2.0 and 8.0 mu g/ml; roxithromycin, 2.0 and 4.0 mg/ml; clarithromycin, 0.25 and 1.0 mu g/ml; azithromycin, 2.0 and 4.0 mu g/ml; levofloxacin, 1.0 and 2.0 mu g/ml; and moxifloxacin, 0.5 and 0.5 mu g/ml, respectively. The MIC values after 24 h and 48 h incubation differed by no more than one dilution for all the agents with the exception of doxycycline (two dilution difference for MIC90). Overall, moxifloxacin was the most active agent in vitro against U. urealyticum, with the narrowest difference between MIC and MBC values, followed closely by levofloxacin. Clarithromycin was the most active macrolide.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available